Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Andrade Robert received 1,703 Fennec Pharmaceuticals Inc. shares as an award (Form 4)
Traded Sep 30, 2026 · Filed Oct 1, 2026
On Sep 30, 2026, Andrade Robert (CHIEF FINANCIAL OFFICER) received 1,703 Fennec Pharmaceuticals Inc. shares as an award, leaving 243,009 shares. Filed Oct 1, 2026 (Form 4).
- Awarded
- 1,703 shares
- Holding after
- 243,009 shares
- Trading plan
- No
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Common shares | Award | 1,703 | 243,009 | Direct |
Source
Related
- Fennec Pharmaceuticals Inc.
- Andrade Robert
- Fennec Pharmaceuticals Inc. shareholders
- Form 4 · Andrade Robert · Nov 2, 2026
- Form 4 · Andrade Robert · Oct 13, 2026
- Form 4 · Andrade Robert · Aug 31, 2026
- Form 4 · Andrade Robert · Aug 28, 2026
- Form 4 · Andrade Robert · Aug 3, 2026
- Form 4 · Brughera Marco Maria · Nov 16, 2026
- Schedule 13G/A · Lawrence Kam · Nov 16, 2026
- Schedule 13G/A · Solas Capital Management, LLC · Nov 16, 2026
- Form 4 · Cioffi Christiana Marie · Nov 2, 2026
- Form 4 · Evans Terry L · Nov 2, 2026